Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · see citing works

[20] Processing of X-ray diffraction data collected in oscillation mode

Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475 · see citing works

<i>Coot</i> : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · see citing works

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,720 · see citing works

Histone deacetylases and cancer: causes and therapies

Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · see citing works

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,856 · see citing works

Chemistry and biology of siderophores

Hider, R. C., & Kong, X. (2010) · Natural Product Reports · doi:10.1039/b906679a · Cited by 1,722 · see citing works

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · see citing works

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Mann, B. S., Johnson, J. R., Cohen, M. H., Justice, R., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-10-1247 · Cited by 1,365 · see citing works

Decreased histone deacetylase activity in chronic obstructive pulmonary disease.

Ito, K., Ito, M., Elliott, W., Cosío, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 1,043 · see citing works

Refinement of severely incomplete structures with maximum likelihood inBUSTER–TNT

Blanc, E., Roversi, P., Vonrhein, C., Flensburg, C., Lea, S. M., & Bricogne, G. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904016427 · Cited by 719 · see citing works

Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases

Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · see citing works

Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor

Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638 · see citing works

Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

Miller, K. M., Tjeertes, J. V., Coates, J., Legube, G., Polo, S. E., Britton, S., & Jackson, S. P. (2010) · Nature Structural &amp; Molecular Biology · doi:10.1038/nsmb.1899 · Cited by 629 · see citing works

Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.

(2011) · PubMed Central · Cited by 560 · see citing works

Deacetylase Enzymes

Grozinger, C. M., & Schreiber, S. L. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00092-3 · Cited by 537 · see citing works

A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas

Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458 · see citing works

Inside HDAC with HDAC inhibitors

Bertrand, P. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.02.030 · Cited by 363 · see citing works

Isoform-selective histone deacetylase inhibitors

Bieliauskas, A. V., & Pflum, M. K. H. (2008) · Chemical Society Reviews · doi:10.1039/b703830p · Cited by 350 · see citing works

Thiamine Pyrophosphate Riboswitches Are Targets for the Antimicrobial Compound Pyrithiamine

Sudarsan, N., Cohen‐Chalamish, S., Nakamura, S., Emilsson, G. M., & Breaker, R. R. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.10.007 · Cited by 268 · see citing works

Structural Studies of Human Histone Deacetylase 8 and Its Site-Specific Variants Complexed with Substrate and Inhibitors^,

Dowling, D. P., Gantt, S. L., Gattis, S. G., Fierke, C. A., & Christianson, D. W. (2008) · Biochemistry · doi:10.1021/bi801610c · Cited by 200 · see citing works

Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors

KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E. M., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 195 · see citing works

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Methot, J. L., Chakravarty, P. K., Chenard, M., Close, J., Cruz, J. C., Dahlberg, W. K., Fleming, J., Hamblett, C. L., Hamill, J. E., Harrington, P., et al. (2008) · Bioorganic &amp; Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.031 · Cited by 191 · see citing works

Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity

Moradei, O. M., Mallais, T. C., Frechette, S., Paquin, I., Tessier, P. E., Leit, S. M., Fournel, M., Bonfils, C., Trachy-Bourget, M.-C., Liu, J., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701079h · Cited by 166 · see citing works

Crystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue

Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 157 · see citing works

Choice of data-collection parameters based on statistic modelling

Popov, A. N., & Bourenkov, G. P. (2003) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444903008163 · Cited by 114 · see citing works

Histone Deacetylase: A Target for Antiproliferative and Antiprotozoal Agents

Meinke, P. T., & Liberator, P. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373787 · Cited by 103 · see citing works

Discovery of histone deacetylase 8 selective inhibitors

Tang, W., Luo, T., Greenberg, E. F., Bradner, J. E., & Schreiber, S. L. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.134 · Cited by 95 · see citing works

Will broad-spectrum histone deacetylase inhibitors be superseded by more specific compounds?

Karagiannis, T. C., & El‐Osta, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404464 · Cited by 95 · see citing works

Functional metal ions in nucleic acids

Müller, J. (2010) · Metallomics · doi:10.1039/c000429d · Cited by 94 · see citing works

Optimization of biaryl Selective HDAC1&amp;2 Inhibitors (SHI-1:2)

Witter, D. J., Harrington, P., Wilson, K. J., Chenard, M., Fleming, J. C., Haines, B., Kral, A. M., Secrist, J. P., & Miller, T. A. (2008) · Bioorganic &amp; Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.047 · Cited by 93 · see citing works

Mercurial-promoted Zn2+ release from Escherichia coli aspartate transcarbamoylase.

Hunt, J. B., Neece, S. H., Schachman, H. K., & Ginsburg, A. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42673-1 · Cited by 91 · see citing works

Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations

Gantt, S. L., Joseph, C. G., & Fierke, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033399 · Cited by 87 · see citing works

On the inhibition of histone deacetylase 8

Estiu, G. L., West, N. H., Mazitschek, R., Greenberg, E. F., Bradner, J. E., & Wiest, O. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.080 · Cited by 84 · see citing works

Interactions between Bortezomib and Romidepsin and Belinostat in Chronic Lymphocytic Leukemia Cells

Dai, Y., Chen, S., Kramer, L. B., Funk, V. L., Dent, P., & Grant, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1934 · Cited by 82 · see citing works

Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy

Mukherjee, P. K., Pradhan, A., Shah, F., Tekwani, B. L., & Avery, M. A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.005 · Cited by 66 · see citing works

Inhibition of Histone Deacetylation Induces Constitutive Derepression of the Beta Interferon Promoter and Confers Antiviral Activity

Shestakova, E. A., Bandu, M., Doly, J., & Bonnefoy, E. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3444-3452.2001 · Cited by 58 · see citing works

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Monovich, L. G., Tommasi, R., Fujimoto, R. A., Blancuzzi, V., Clark, K., Cornell, W. D., Doti, R. A., Doughty, J., Fang, J. C., FARLEY, D. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801394m · Cited by 58 · see citing works

Rational Design of MOFs Constructed from Modified Aromatic Amino Acids

Xie, Y., Yu, Z., Huang, X., Wang, Z., Niu, L., Teng, M., & Li, J. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200700543 · Cited by 53 · see citing works

Structural Analysis of Cadmium–Glycylglycine Complexes Studied by X-Ray Diffraction and High Resolution 113Cd and 13C Solid State NMR

Takayama, T., Ohuchida, S., Koike, Y., Watanabe, M., Hashizume, D., & Ohashi, Y. (1996) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.69.1579 · Cited by 46 · see citing works

Conformational Refinement of Hydroxamate-Based Histone Deacetylase Inhibitors and Exploration of 3-Piperidin-3-ylindole Analogues of Dacinostat (LAQ824)

Cho, Y. S., Whitehead, L., Li, J., Chen, C. H. ‐., Jiang, L., Vögtle, M., Francotte, E. R., Richert, P., Wagner, T., Traebert, M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100007m · Cited by 35 · see citing works

New Bioactive Zinc(II) Complexes with Peptides and Their Derivatives: Synthesis, Structure, and In Vitro Insulinomimetic Activity

Ueda, E., Yoshikawa, Y., Kishimoto, N., Tadokoro, M., Sakurai, H., Kajiwara, N., & Kojima, Y. (2004) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.77.981 · Cited by 34 · see citing works

Structures and reactivity of synthetic zinc(ii) complexes resembling the active sites and reaction intermediates of aminopeptidasesElectronic supplementary information (ESI) available: Experimental details (synthesis, characterization and hydrolysis studies). See http://www.rsc.org/suppdata/cc/b3/b314089j/

Rivas, J. C. M., Salvagni, E., & Parsons, S. (2004) · Chemical Communications · doi:10.1039/b314089j · Cited by 12 · see citing works

Synthesis, structural study and topological analysis of Zn/Aib and Aib-based small peptide complexes (H-Aib-OH=α-aminoisobutyric acid)

Katsoulakou, E., Papaefstathiou, G. S., Konidaris, K. F., Pairas, G., Raptopoulou, C. P., Cordopatis, P. A., & Manessi‐Zoupa, E. (2009) · Polyhedron · doi:10.1016/j.poly.2009.07.005 · Cited by 11 · see citing works

Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists

Lim, J. W., Oh, Y., Kim, J., Oak, M., Na, Y.-H., Lee, J.-O., Lee, S. W., Cho, H., Park, W., Choi, G., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.072 · Cited by 6 · see citing works

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight

Ho, T. C. S., Chan, A. H. Y., & Ganesan, A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00830 · Cited by 795 · see citing works

Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability

Lauffer, B. E. L., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., Flicke, B., Ritscher, A., Fedorowicz, G., Vallero, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490706 · Cited by 429 · see citing works

Targeted Cancer Therapy: Giving Histone Deacetylase Inhibitors All They Need To Succeed

Gryder, B. E., Sodji, Q. H., & Oyelere, A. K. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.3 · Cited by 404 · see citing works

Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics

Ali, I., Conrad, R. J., Verdin, E. M., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366 · see citing works

Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors—What Some May Have Forgotten or Would Rather Forget?

Shen, S., & Kozikowski, A. P. (2016) · ChemMedChem · doi:10.1002/cmdc.201500486 · Cited by 288 · see citing works

HDAC8: a multifaceted target for therapeutic interventions

Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284 · see citing works

Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes

Lombardi, P. M., Cole, K., Dowling, D., & Christianson, D. W. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.004 · Cited by 279 · see citing works

Targeting Metalloenzymes for Therapeutic Intervention

Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 277 · see citing works

Histone deacetylases: structural determinants of inhibitor selectivity

Micelli, C., & Rastelli, G. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.007 · Cited by 196 · see citing works

Targeting Class I Histone Deacetylases in a “Complex” Environment

Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180 · see citing works

Histone deacetylase 11 is a fatty-acid deacylase

Kutil, Z., Novakova, Z., Meleshin, M., Mikesova, J., Schutkowski, M., & Barinka, C. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00942 · Cited by 174 · see citing works

Rapid Discovery of Highly Potent and Selective Inhibitors of Histone Deacetylase 8 Using Click Chemistry to Generate Candidate Libraries

Suzuki, T., Ota, Y., Ri, M., Bando, M., Gotoh, A., Itoh, Y., Tsumoto, H., Tatum, P. R., Mizukami, T., Nakagawa, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300837y · Cited by 165 · see citing works

Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants

Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 123 · see citing works

New techniques and strategies in drug discovery

Du, J., Guo, J., Kang, D., Li, Z., Wang, G., Wu, J., Zhang, Z., Fang, H., Hou, X., Huang, Z., et al. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.03.028 · Cited by 122 · see citing works

Strategies To Design Selective Histone Deacetylase Inhibitors

Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118 · see citing works

Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview

Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 113 · see citing works

Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases

Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111 · see citing works

Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases

Wagner, F. F., Weïwer, M., Lewis, M. C., & Holson, E. B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0226-1 · Cited by 99 · see citing works

Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next

Thaler, F., & Mercurio, C. (2013) · ChemMedChem · doi:10.1002/cmdc.201300413 · Cited by 95 · see citing works

Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity

Heimburg, T., Kolbinger, F. R., Zeyen, P., Ghazy, E., Herp, D., Schmidtkunz, K., Melesina, J., Shaik, T. B., Erdmann, F., Schmidt, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01447 · Cited by 92 · see citing works

HDAC8 substrates: Histones and beyond

Wolfson, N. A., Pitcairn, C. A., & Fierke, C. A. (2012) · Biopolymers · doi:10.1002/bip.22135 · Cited by 82 · see citing works

Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities

Rodrigues, D. A., Pinheiro, P. D. S. M., Sagrillo, F. S., Bolognesi, M. L., & Fraga, C. A. M. (2020) · Medicinal Research Reviews · doi:10.1002/med.21701 · Cited by 72 · see citing works

Molecular Basis for the Antiparasitic Activity of a Mercaptoacetamide Derivative That Inhibits Histone Deacetylase 8 (HDAC8) from the Human Pathogen Schistosoma mansoni

Stolfa, D. A., Marek, M., Lancelot, J., Hauser, A.-T., Walter, A., Leproult, E., Melesina, J., Rumpf, T., Wurtz, J.-M., Cavarelli, J., et al. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.007 · Cited by 75 · see citing works

Zinc-dependent Deacetylase (HDAC) Inhibitors with Different Zinc Binding Groups

Li, Y., Wang, F., Chen, X., Wang, J., Zhao, Y., Li, Y., & He, B. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190122144949 · Cited by 75 · see citing works

Innovative Strategies for Selective Inhibition of Histone Deacetylases

Maolanon, A. R., Madsen, A. S., & Olsen, C. A. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.06.011 · Cited by 72 · see citing works

Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors

Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300414 · Cited by 71 · see citing works

Design of dual MMP-2/HDAC-8 inhibitors by pharmacophore mapping, molecular docking, synthesis and biological activity

Halder, A. K., Mallick, S., Shikha, D., Saha, A., Saha, K. D., & Jha, T. (2015) · RSC Advances · doi:10.1039/c5ra12606a · Cited by 71 · see citing works

Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?

Amin, S. A., Adhikari, N., & Jha, T. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.002 · Cited by 71 · see citing works

The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors

Cao, F., Zwinderman, M., & Dekker, F. (2018) · Molecules · doi:10.3390/molecules23030551 · Cited by 66 · see citing works

Mechanistic basis and preliminary practice of butyric acid and butyrate sodium to mitigate gut inflammatory diseases: a comprehensive review

Zhang, M., Wang, Y., Zhao, X., Liu, C., Wang, B., & Zhou, J. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.08.007 · Cited by 66 · see citing works

Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives

Andreoli, F., Barbosa, A. J. M., Parenti, M. D., & Río, A. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581918 · Cited by 68 · see citing works

Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms

Zessin, M., Meleshin, M., Praetorius, L., Sippl, W., Bařinka, C., & Schutkowski, M. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00863 · Cited by 64 · see citing works

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)

Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62 · see citing works

An Automated Strategy for Binding-Pose Selection and Docking Assessment in Structure-Based Drug Design

Ballante, F., & Marshall, G. R. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00603 · Cited by 62 · see citing works

Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases

Frühauf, A., & Meyer‐Almes, F. (2021) · Molecules · doi:10.3390/molecules26175151 · Cited by 58 · see citing works

Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation

Upadhyay, N., Tilekar, K. N., Jänsch, N., Schweipert, M., Hess, J. D., Macias, L. G.-F., Mrówka, P., Aguilera, R. J., Choe, J., Meyer‐Almes, F., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103934 · Cited by 56 · see citing works

HDACs and the epigenetic plasticity of cancer cells: target the complexity

Brancolini, C., Gagliano, T., & Minisini, M. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108190 · Cited by 55 · see citing works

The enzyme activity of histone deacetylase 8 is modulated by a redox-switch

Jänsch, N., Meyners, C., Muth, M., Kopranovic, A., Witt, O., Oehme, I., & Meyer‐Almes, F. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.013 · Cited by 50 · see citing works

Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines

Tilekar, K. N., Upadhyay, N., Jänsch, N., Schweipert, M., Mrówka, P., Meyer‐Almes, F., & Ramaa, C. S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103522 · Cited by 50 · see citing works

Structure–Activity Relationships and Blood Distribution of Antiplasmodial Aminopeptidase-1 Inhibitors

Deprez-Poulain, R. F., Flipo, M., Piveteau, C., Leroux, F., Dassonneville, S., Florent, I., Maes, L. J. R. M., Cos, P., & Deprez, B. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301506h · Cited by 48 · see citing works

Mutagenesis Studies of the 14 Å Internal Cavity of Histone Deacetylase 1: Insights toward the Acetate-Escape Hypothesis and Selective Inhibitor Design

Wambua, M. K., Nalawansha, D. A., Negmeldin, A. T., & Pflum, M. K. H. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401837e · Cited by 48 · see citing works

Structure-activity relationships of HDAC8 inhibitors: Non-hydroxamates as anticancer agents

Amin, S. A., Adhikari, N., & Jha, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.001 · Cited by 50 · see citing works

Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes

Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.009 · Cited by 47 · see citing works

Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors

Wang, L., Hou, X., Fu, H., Pan, X., Xu, W., Tang, W., & Fang, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.06.024 · Cited by 47 · see citing works

Bifunctional HDAC Therapeutics: One Drug to Rule Them All?

Smalley, J. P., Cowley, S. M., & Hodgkinson, J. T. (2020) · Molecules · doi:10.3390/molecules25194394 · Cited by 47 · see citing works

Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors

Melesina, J., Robaa, D., Pierce, R. J., Romier, C., & Sippl, W. (2015) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2015.10.006 · Cited by 46 · see citing works

Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity

Darwish, S., Ghazy, E., Heimburg, T., Herp, D., Zeyen, P., Salem-Altintas, R., Ridinger, J., Schmidtkunz, K., Robaa, D., Erdmann, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147535 · Cited by 45 · see citing works

A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing

Simoben, C., Robaa, D., Chakrabarti, A., Schmidtkunz, K., Marek, M., Lancelot, J., Kannan, S., Melesina, J., Shaik, T., Pierce, R., et al. (2018) · Molecules · doi:10.3390/molecules23030566 · Cited by 44 · see citing works

Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8

Hou, X., Du, J., Liu, R., Zhou, Y., Li, M., Xu, W., & Fang, H. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500762z · Cited by 43 · see citing works

Exploring Inhibitor Release Pathways in Histone Deacetylases Using Random Acceleration Molecular Dynamics Simulations

Kalyaanamoorthy, S., & Chen, Y. P. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200584f · Cited by 42 · see citing works

Potent and Selective Non‐hydroxamate Histone Deacetylase 8 Inhibitors

Kleinschek, A., Meyners, C., Giorgio, E. D., Brancolini, C., & Meyer‐Almes, F. (2016) · ChemMedChem · doi:10.1002/cmdc.201600528 · Cited by 41 · see citing works

Structure–Activity Relationships of Hydroxamate-Based Histone Deacetylase-8 Inhibitors: Reality Behind Anticancer Drug Discovery

Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 41 · see citing works

A distal regulatory region of a class I human histone deacetylase

Werbeck, N. D., Shukla, V. K., Kunze, M. B. A., Yalinca, H., Pritchard, R. B., Siemons, L., Mondal, S., Greenwood, S. O. R., Kirkpatrick, J., Marson, C. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17610-w · Cited by 40 · see citing works

Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay

Uba, A. İ., & Yelekçi, K. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1384402 · Cited by 39 · see citing works

HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides

Castañeda, C. A., Wolfson, N. A., Leng, K. W., Kuo, Y., Andrews, A. J., & Fierke, C. A. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.811026 · Cited by 39 · see citing works

Zinc enzymes in medicinal chemistry

Hou, R., He, Y., Yan, G., Hou, S., Xie, Z., & Liao, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113877 · Cited by 38 · see citing works

Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)

Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00115 · Cited by 36 · see citing works

Synthesis and Structure–Activity Relationship of 3-Hydroxypyridine-2-thione-Based Histone Deacetylase Inhibitors

Sodji, Q. H., Patil, V., Kornacki, J. R., Mrksich, M., & Oyelere, A. K. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401225q · Cited by 36 · see citing works

How the flexibility of human histone deacetylases influences ligand binding: an overview

Deschamps, N., Simões‐Pires, C. A., Carrupt, P., & Nurisso, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.004 · Cited by 36 · see citing works

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article

Wagih, N., Abdel-Rahman, I. M., El‐Koussi, N. A., & Abuo‐Rahma, G. E. A. (2025) · RSC Advances · doi:10.1039/d4ra05014b · Cited by 35 · see citing works

Synthesis and structure activity relationship of 1, 3-benzo-thiazine-2-thiones as selective HDAC8 inhibitors

Wolff, B., Jänsch, N., Sugiarto, W. O., Frühschulz, S., Lang, M., Altintas, R., Oehme, I., & Meyer‐Almes, F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111756 · Cited by 34 · see citing works

Diverse Classes of HDAC8 Inhibitors: In Search of Molecular Fingerprints that Regulate Activity

Amin, S. A., Adhikari, N., & Jha, T. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0005 · Cited by 33 · see citing works

Resolving the deceptive isoform and complex selectivity of HDAC1/2 inhibitors

Payne, N. C., & Mazitschek, R. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.03.002 · Cited by 32 · see citing works

The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors

Shultz, M. D., Fan, J., Chen, C., Cho, Y. S., Davis, N., Bickford, S., Buteau, K., Cao, X., Holmqvist, M., Hsu, M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.015 · Cited by 32 · see citing works

Design and Synthesis of Simplified Largazole Analogues as Isoform-Selective Human Lysine Deacetylase Inhibitors

Reddy, D. N., Ballante, F., Chuang, T., Pirolli, A., Marrocco, B., & Marshall, G. R. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01632 · Cited by 31 · see citing works

Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?

Amin, S. A., Khatun, S., Gayen, S., Das, S., & Jha, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115594 · Cited by 31 · see citing works

HIt Discovery using docking ENriched by GEnerative Modeling (HIDDEN GEM): A novel computational workflow for accelerated virtual screening of ultra‐large chemical libraries

Popov, K. I., Wellnitz, J., Maxfield, T., & Tropsha, A. (2023) · Molecular Informatics · doi:10.1002/minf.202300207 · Cited by 29 · see citing works

Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue

Almaliti, J., Al-Hamashi, A. A., Negmeldin, A. T., Hanigan, C. L., Perera, L., Pflum, M. K. H., Casero, R. A., & Tillekeratne, L. M. V. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01271 · Cited by 29 · see citing works

Intrinsic structural dynamics dictate enzymatic activity and inhibition

Shukla, V. K., Siemons, L., & Hansen, D. F. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310910120 · Cited by 29 · see citing works

Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides

Wutz, D., Gluhacevic, D., Chakrabarti, A., Schmidtkunz, K., Robaa, D., Erdmann, F., Romier, C., Sippl, W., Jung, M., & König, B. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00976c · Cited by 29 · see citing works

Selective and Nonselective HDAC8 Inhibitors: a Therapeutic Patent Review

Adhikari, N., Amin, S. A., & Jha, T. (2018) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2018-0019 · Cited by 27 · see citing works

Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies

Sixto‐López, Y., Gómez-Vidal, J. A., & Correa‐Basurto, J. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0976-1 · Cited by 26 · see citing works

Histone Deacetylase Inhibitors: Structure-Based Modeling and Isoform-Selectivity Prediction

Silvestri, L., Ballante, F., Mai, A., Marshall, G. R., & Ragno, R. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300160y · Cited by 26 · see citing works

Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8

Xiao, Y., Awasthee, N., Liu, Y., Meng, C., He, M. Y., Hale, S. M., Karki, R., Lin, Z., Mosterio, M., Garcia, B. A., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00761 · Cited by 25 · see citing works

Synthesis of N′-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV)

Kozlov, M. V., Konduktorov, K. A., Shcherbakova, A. S., & Kochetkov, S. N. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.06.006 · Cited by 26 · see citing works

Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 Inhibitor

Tamanini, E., Miyamura, S., Buck, I. M., Cons, B. D., Dawson, L., East, C., Futamura, T., Goto, S., Griffiths-Jones, C., Hashimoto, T., et al. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00272 · Cited by 25 · see citing works

Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation

Uba, A. İ., Weako, J., Keskin, Ö., Gürsoy, A., & Yelekçi, K. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1615989 · Cited by 23 · see citing works

HDAC8 as a target in drug discovery: Function, structure and design

Zhao, Q., Liu, H., Peng, J., Niu, H., Liu, J., Xue, H., Liu, W., Liu, X., Hao, H., Zhang, X., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116972 · Cited by 23 · see citing works

Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups

Bhansali, P. R., Hanigan, C. L., Perera, L., Casero, R. A., & Tillekeratne, L. M. V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.009 · Cited by 22 · see citing works

Design and synthesis of benzodiazepine analogs as isoform-selective human lysine deacetylase inhibitors

Reddy, D. R., Ballante, F., Zhou, N., & Marshall, G. R. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.032 · Cited by 22 · see citing works

Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies

Uba, A. İ., & Yelekçi, K. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.05.004 · Cited by 22 · see citing works

Covalent inhibition of histone deacetylase 8 by 3,4-dihydro-2H-pyrimido[1,2-c][1,3]benzothiazin-6-imine

Muth, M., Jänsch, N., Kopranovic, A., Krämer, A., Wössner, N., Jung, M., Kirschhöfer, F., Brenner‐Weiß, G., & Meyer‐Almes, F. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.01.001 · Cited by 22 · see citing works

Design, synthesis and tumor cell growth inhibitory activity of 3-nitro-2H-cheromene derivatives as histone deacetylaes inhibitors

Tan, S., He, F., Kong, T., Wu, J., & Liu, Z. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.05.062 · Cited by 21 · see citing works

Molecular structures guide the engineering of chromatin

Tekel, S. J., & Haynes, K. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx531 · Cited by 21 · see citing works

Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury

Long, K. E., Vaughn, Z., McDaniels, M. D., Joyasawal, S., Przepiorski, A. J., Parasky, E., Sander, V., Close, D. A., Johnston, P. A., Davidson, A. J., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00243 · Cited by 20 · see citing works

Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study

Baselious, F., Robaa, D., & Sippl, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107700 · Cited by 20 · see citing works

Methyl Effect in Azumamides Provides Insight Into Histone Deacetylase Inhibition by Macrocycles

Maolanon, A. R., Villadsen, J. S., Christensen, N. J., Hoeck, C. R., Friis, T., Harris, P., Gotfredsen, C. H., Fristrup, P., & Olsen, C. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501399d · Cited by 20 · see citing works

Design of Selective Histone Deacetylase Inhibitors: Rethinking Classical Pharmacophore

Melesina, J., Praetorius, L., Simoben, C. V., Robaa, D., & Sippl, W. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0125 · Cited by 21 · see citing works

One‐pot synthesis of anilides, herbicidal activity and molecular docking study

Sartori, S. K., Alvarenga, E. S., Franco, C. A., Ramos, D. S., & de Oliveira, D. F. (2018) · Pest Management Science · doi:10.1002/ps.4855 · Cited by 18 · see citing works

Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors

Keeley, A. B., Kopranovic, A., Lorenzo, V. D., Ábrányi‐Balogh, P., Jänsch, N., Lai, L. N., Petri, L., Orgován, Z., Pölöske, D., Orlova, A., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01779 · Cited by 17 · see citing works

Development of second generation epigenetic agents

JONES, P. G. (2011) · MedChemComm · doi:10.1039/c1md00199j · Cited by 17 · see citing works

Discovery of novel tetrahydrobenzo[b]thiophene-3-carbonitriles as histone deacetylase inhibitors

Gediya, P., Vyas, V. K., Carafa, V., Sitwala, N. D., Torre, L. D., Poziello, A., Kurohara, T., Suzuki, T., Sanna, V. K., Raguraman, V., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104801 · Cited by 16 · see citing works

Exploring structural requirements of isoform selective histone deacetylase inhibitors: a comparative in silico study

Kashyap, K., & Kakkar, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1711191 · Cited by 16 · see citing works

Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit

Greenwood, S. O. R., Chan, A. W. E., Hansen, D. F., & Marson, C. M. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126926 · Cited by 16 · see citing works

Ligand release mechanisms and channels in histone deacetylases

Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Journal of Computational Chemistry · doi:10.1002/jcc.23390 · Cited by 15 · see citing works

Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition

King, K., Hauser, A., Melesina, J., Sippl, W., & Jung, M. (2018) · Molecules · doi:10.3390/molecules23020321 · Cited by 15 · see citing works

Molecular dynamics study of HDAC8-largazole analogues co-crystals for designing potential anticancer compounds

Dewaker, V., Srivastava, P. N., Verma, S. K., & Prabhakar, Y. S. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1598497 · Cited by 14 · see citing works

Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity

Baselious, F., Hilscher, S., Hagemann, S., Tripathee, S., Robaa, D., Barinka, C., Hüttelmaier, S., Schutkowski, M., & Sippl, W. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202400486 · Cited by 16 · see citing works

Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy

Ballante, F., Reddy, D. R., Zhou, N., & Marshall, G. R. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.020 · Cited by 13 · see citing works

Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules

Paneth, A., Kaproń, B., Plech, T., Paduch, R., Trotsko, N., & Paneth, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417521 · Cited by 12 · see citing works

Identification of novel HDAC8 selective inhibitors through ligand and structure based studies: Exploiting the acetate release channel differences among class I isoforms

Vema, A., Debnath, S., & Kalle, A. M. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103863 · Cited by 11 · see citing works

Toward Selective Histone Deacetylase Inhibitor Design: Homology Modeling, Docking Studies, and Molecular Dynamics Simulations of Human Class I Histone Deacetylases

Wang, D., Helquist, P. M., Wiech, N. L., & Wiest, O. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0505011 · Cited by 210 · see citing works

Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors

KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E. M., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 195 · see citing works

Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants

Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 123 · see citing works

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)

Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62 · see citing works